Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

Chad A. Brown; Jack L. Lesher; Christopher M. Peterson

Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

Chad A. Brown, Jack L. Lesher, Christopher M. Peterson

Medicine

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Xanthomas most often occur in conjunction with a primary or secondary disorder of lipid metabolism. A range of metabolic disturbances has been described in association with protease inhibitors, including lipodystrophy, hyperglycemia, and hyperlipidemia. Ritonavir has been repeatedly shown to be the most common protease inhibitor to induce these metabolic abnormalities. This report highlights a case of both tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

Original language	English (US)
Pages (from-to)	S86-89
Journal	Journal of the American Academy of Dermatology
Volume	52
Issue number	5 Suppl 1
State	Published - May 2005

ASJC Scopus subject areas

Dermatology

Cite this

@article{7f7cd593a07e420da3b1a27940d1eb26,

title = "Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.",

abstract = "Xanthomas most often occur in conjunction with a primary or secondary disorder of lipid metabolism. A range of metabolic disturbances has been described in association with protease inhibitors, including lipodystrophy, hyperglycemia, and hyperlipidemia. Ritonavir has been repeatedly shown to be the most common protease inhibitor to induce these metabolic abnormalities. This report highlights a case of both tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.",

author = "Brown, {Chad A.} and Lesher, {Jack L.} and Peterson, {Christopher M.}",

year = "2005",

month = may,

language = "English (US)",

volume = "52",

pages = "S86--89",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "5 Suppl 1",

}

TY - JOUR

T1 - Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

AU - Brown, Chad A.

AU - Lesher, Jack L.

AU - Peterson, Christopher M.

PY - 2005/5

Y1 - 2005/5

N2 - Xanthomas most often occur in conjunction with a primary or secondary disorder of lipid metabolism. A range of metabolic disturbances has been described in association with protease inhibitors, including lipodystrophy, hyperglycemia, and hyperlipidemia. Ritonavir has been repeatedly shown to be the most common protease inhibitor to induce these metabolic abnormalities. This report highlights a case of both tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

AB - Xanthomas most often occur in conjunction with a primary or secondary disorder of lipid metabolism. A range of metabolic disturbances has been described in association with protease inhibitors, including lipodystrophy, hyperglycemia, and hyperlipidemia. Ritonavir has been repeatedly shown to be the most common protease inhibitor to induce these metabolic abnormalities. This report highlights a case of both tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

UR - http://www.scopus.com/inward/record.url?scp=33644876125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644876125&partnerID=8YFLogxK

M3 - Article

C2 - 15858517

AN - SCOPUS:33644876125

SN - 0190-9622

VL - 52

SP - S86-89

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5 Suppl 1

ER -

Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia.

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this